secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2026-05-21T20:59:16+00:00
Accession:  0001493152-26-024850
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics raises ~$4.0M in private placement at $1.405/unit
---------------------------------------------------------------

- Sold 2,846,975 units at $1.405 each, each comprising 1 share (or pre-funded warrant at $1.2799) and 1 warrant exercisable at $1.28.
- Gross proceeds of ~$4.0M before fees; net proceeds for HCW9302 clinical trials and IND-enabling studies for HCW11-018b and HCW11-040.
- E.F. Hutton acted as sole placement agent; closing expected May 21, 2026.
- Registration rights agreement filed within 60 days; warrants expire 5.5 years from issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226024850/0001493152-26-024850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226024850/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-024850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer